|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| C07K 14/72 | (2006.01) | ||
| A61K 38/08 | (2019.01) | ||
| A61K 38/04 | (2006.01) |
| (11) | Number of the document | 3539551 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19158126.3 |
| Date of filing the European patent application | 2012-12-28 | |
| (97) | Date of publication of the European application | 2019-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
| (46) | Date of publication of the claims translation | 2022-01-10 |
| (30) | Number | Date | Country code |
| 201161581391 P | 2011-12-29 | US |
| (72) |
TARTAGLIA, Louis, A. , US
HENDERSON, Bart , US
|
| (73) |
Rhythm Pharmaceuticals, Inc. ,
222 Berkeley Street, 12th floor, Boston, MA 02116,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Su melanokortino-4 receptoriumi susijusių sutrikimų gydymo būdas heterozigotiniuose nešiotojuose |
| METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS |
| Payment date | Validity (years) | Amount | |
| 2025-12-02 | 14 | 289.00 EUR |
| 2026-12-28 |